We just received data on a new analyst forecast for $XRAY. Jeffrey Johnson from Baird set a price target of 12.0 for XRAY.
To track analyst ratings and price targets for $XRAY, check out Quiver Quantitative's $XRAY forecast page.
Should you buy $XRAY?
Some analysts are better than others. To view the past performance of Baird, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$XRAY Price Targets
Multiple analysts have issued price targets for $XRAY recently. We have seen 8 analysts offer price targets for $XRAY in the last 6 months, with a median target of $12.5.
Here are some recent targets:
- Jeffrey Johnson from Baird set a target price of $12.0 on 12/16/2025
- Glen Santangelo from Barclays set a target price of $12.0 on 12/09/2025
- Michael Petusky from Barrington Research set a target price of $14.0 on 11/10/2025
- Lilia-Celine Lozada from JP Morgan set a target price of $12.0 on 11/07/2025
- Vik Chopra from Wells Fargo set a target price of $12.0 on 11/07/2025
- Kevin Caliendo from UBS set a target price of $23.0 on 10/28/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $13.0 on 10/08/2025
$XRAY Insider Trading Activity
$XRAY insiders have traded $XRAY stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:
- GREGORY T LUCIER sold 82,200 shares for an estimated $915,708
- LESLIE F VARON purchased 9,337 shares for an estimated $99,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XRAY Revenue
$XRAY had revenues of $904M in Q3 2025. This is a decrease of -4.94% from the same period in the prior year.
You can track XRAY financials on Quiver Quantitative's XRAY stock page.
$XRAY Hedge Fund Activity
We have seen 238 institutional investors add shares of $XRAY stock to their portfolio, and 203 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 10,749,500 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $136,411,155
- NUANCE INVESTMENTS, LLC removed 8,987,359 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $142,719,260
- ARMISTICE CAPITAL, LLC added 5,234,587 shares (+1044.0%) to their portfolio in Q3 2025, for an estimated $66,426,909
- JACOBS LEVY EQUITY MANAGEMENT, INC added 4,003,606 shares (+662.0%) to their portfolio in Q3 2025, for an estimated $50,805,760
- D. E. SHAW & CO., INC. added 1,669,643 shares (+136.1%) to their portfolio in Q3 2025, for an estimated $21,187,769
- BRICKWOOD ASSET MANAGEMENT LLP added 1,496,935 shares (+5515.8%) to their portfolio in Q3 2025, for an estimated $18,996,105
- INVENOMIC CAPITAL MANAGEMENT LP added 1,425,637 shares (+48.7%) to their portfolio in Q3 2025, for an estimated $18,091,333
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
